Karah Parschauer

Ms. Parschauer currently serves as the Chief Legal Officer and Executive Vice President of Ultragenyx Pharmaceutical Inc., a public biopharmaceutical company developing treatments for rare and ultra-rare genetic diseases, following five years as the company’s General Counsel and Corporate Secretary beginning in June 2016. From June 2005 to June 2016, Ms. Parschauer served in various executive capacities, most recently as Vice President, Associate General Counsel, at Allergan plc, a pharmaceutical company. Before Allergan, Ms. Parschauer was an attorney at Latham & Watkins LLP, where she practiced in the areas of mergers and acquisitions, securities offerings and corporate governance.

Ms. Parschauer is a member of the board of directors for Evolus, Inc., a publicly traded performance beauty company. She is also a member of the board of directors for Anebulo Pharmaceuticals, Inc., a publicly traded clinical-stage biopharmaceutical company. From June 2019 to August 2021, she was a member of the board of directors of Arcturus Therapeutics Holdings Inc., a publicly traded RNA medicines company. Ms. Parschauer holds a B.A. from Miami University and a J.D. from Harvard Law School.